Hemgenix is supplied ‘conditional authorisation’. This means that the eu Medicines Agency decided that the main advantages of Hemgenix are larger than its pitfalls, but the business will have to offer more evidence after authorisation.According to the scientific gurus consulted by CADTH, there are several unmet requires for hemophilia B. Initia